GammaRips
Back to Signals

OSCR

BULL
2026-05-19

Overnight Institutional Flow Signal

Score
6/10
Move
8.0%
Flow
$3.7M
AI Trade Thesis
OSCR BULL $27.5C Jun 05 '26. Fundamental momentum from the Q1 earnings beat and a series of price target hikes to $30.00 suggest the current rally has institutional legs. Entry near $25.30 with a target of $28.50 before the June expiry. Risk: High implied volatility post-earnings and potential profit-taking at the $25.50 resistance level.
Flow Breakdown
Call Volume
$3.4M
Put Volume
$328K
Flow Intent
DIRECTIONAL
Catalyst
Earnings Beat
Recommended Setup
ContractO:OSCR260605C00027500
Contract Score11.072/10
Risk/Reward0.0:1
Delta0.34
Key Levels
Resistance$25.58
Support$16.35
Price$25.30
SMA 50 / 200$16 / $16
52W Range$11$26
News & Catalyst Analysis

Key Headline

Oscar Health Hits 52-Week High as Profits More-Than-Double on Strong Q1 Results

News Summary

Oscar Health's massive Q1 2026 EPS beat ($2.07 vs. $1.06 estimate) and reaffirmed full-year guidance have triggered a structural re-rating of the stock. Institutional flow is aggressively targeting OTM strikes, suggesting that the recent 8% move is viewed as a momentum breakout toward analyst price targets of $30.00.

Flow Intent Analysis

Institutional buyers are targeting OTM calls with a short-dated expiration (June '26) following a breakout, indicating a high-conviction bet on immediate price continuation rather than defensive hedging.

One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest deep-dive, and the picks on the public ledger. No firehose, no FOMO.

Free weekly newsletter. No spam. Unsubscribe anytime.

One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest deep-dive, and the picks on the public ledger. No firehose, no FOMO.

Free weekly newsletter. No spam. Unsubscribe anytime.

    We Use Cookies

    We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.